GlassScriptPhysician profile
David H Jung
NPI 1205031739
$24,111.84
in general payments reported to CMS, 2019-2025
6 companies · $222 in 2025
The $222 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,179 · 2023: $12K · 2024: $11K · 2025: $222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $22K · Food and Beverage: $534 · Travel and Lodging: $98.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $22,300.00 |
| Food and Beverage | $534.09 |
| Travel and Lodging | $98.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eli Lilly and Company | $16,800.00 | 2023-2024 | |
| Stryker Corporation | $3,000.00 | 2024 | |
| Amgen INC. | $2,562.56 | 2024 | Tepezza |
| Med-El Corporation | $1,440.75 | 2019-2024 | Mi1250 Synchrony 2 Flexsoft, Adhear Professional Kit, Bci 602 Kit |
| Advanced Bionics, LLC | $161.06 | 2019-2025 | Hires Ultra Ci Hifocus Ms Electrode |
| Cochlear Americas | $147.47 | 2025 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant, Baha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Jung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.